Andrés C. R.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of RP3 Monotherapy and RP3 Plus Nivolumab in Patients with Advanced Solid Tumors
- Phase I Evaluation of FS222 for Safety and Efficacy in Patients with Advanced Malignancies
- Evaluation of FS120 Monotherapy and FS120 with Pembrolizumab in Patients with Advanced Malignancies: A First-in-Human Safety and Efficacy Study
Data & Insights
Has run more than one trial at 42 of 111 partner sites.
Specializations
Breast Cancer and Gynecologic Oncology
Clinical research activity is centered on hormone receptor-positive breast cancer, HER2-negative breast cancer, triple-negative breast cancer, and HER2-positive breast cancer, with additional involvement in endometrial cancer, ovarian cancer, cervical cancer, and uterine serous carcinoma.
- Advanced breast cancer
- Early breast cancer
- Metastatic ovarian cancer
- Recurrent endometrial and cervical cancer
The therapeutic focus includes biomarker-defined disease, endocrine resistance, and treatment strategies for locally advanced and metastatic solid tumors in women’s cancers.
Thoracic and Gastrointestinal Malignancies
Research involvement extends across non-small cell lung cancer, small cell lung cancer, head and neck squamous cell carcinoma, gastric cancer, gastroesophageal junction adenocarcinoma, and colorectal cancer.
- Metastatic NSCLC
- Resectable lung cancer
- Metastatic colorectal cancer
- Advanced gastric and esophageal cancer
Key interests include mutation-driven solid tumors, recurrent disease, and treatment settings spanning unresectable, locally advanced, and metastatic presentations.
Hematologic Malignancies
The investigator is active in acute myeloid leukemia, myelodysplastic syndrome, myelofibrosis, multiple myeloma, diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.
- Acute leukemia
- Myelodysplastic and myeloproliferative disorders
- B-cell lymphomas
- Plasma cell dyscrasias
Therapeutic interest also includes relapsed or refractory disease, transplant-related care, and molecularly defined hematologic subtypes.
Cardiovascular, Renal, and Metabolic Disease
Clinical trial involvement includes atherosclerotic cardiovascular disease, heart failure, myocardial infarction, atrial fibrillation, chronic kidney disease, hypertension, and dyslipidemia, together with obesity and type 2 diabetes.
- Heart failure syndromes
- Ischemic cardiovascular disease
- Chronic kidney disease
- Metabolic risk disorders
The therapeutic landscape also covers stroke prevention, anticoagulation-related care, and cardiorenal complications linked to systemic inflammation.
Immune-Mediated and Inflammatory Disorders
Additional research activity includes Crohn’s disease, ulcerative colitis, systemic lupus erythematosus, psoriatic arthritis, polymyalgia rheumatica, asthma, chronic obstructive pulmonary disease, and pulmonary sarcoidosis.
- Inflammatory bowel disease
- Autoimmune rheumatic disease
- Chronic airway disease
- Granulomatous lung disease
Therapeutic interest includes immune modulation in chronic inflammatory conditions and organ-specific autoimmune disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.